ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesK59.03

K59.03

Billable

Drug induced constipation

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 K59.03 is a billable code used to indicate a diagnosis of drug induced constipation.

Key Diagnostic Point:

Drug-induced constipation (K59.03) is a gastrointestinal condition characterized by infrequent bowel movements or difficulty passing stools as a direct result of pharmacological agents. The anatomy involved primarily includes the colon and rectum, where the normal peristaltic movement is disrupted by certain medications, leading to stool retention. Common classes of drugs that may induce constipation include opioids, anticholinergics, and certain antidepressants. The clinical presentation may vary from mild discomfort to severe abdominal pain and bloating, often accompanied by a sense of incomplete evacuation. Disease progression can lead to fecal impaction, which may require medical intervention. Diagnostic considerations include a thorough medication history, physical examination, and possibly imaging studies to rule out other causes of constipation. It is essential for healthcare providers to recognize the signs of drug-induced constipation early to modify treatment regimens and alleviate symptoms effectively.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires careful assessment of medication history and potential interactions.
  • Treatment complexity: Management may involve adjusting medications, dietary changes, or prescribing laxatives.
  • Documentation requirements: Detailed documentation of medication use and symptomatology is necessary.
  • Coding specificity: Requires accurate identification of the cause of constipation related to drug use.

Audit Risk Factors

  • Common coding errors: Misidentification of the cause of constipation.
  • Documentation gaps: Incomplete medication history or lack of symptom detail.
  • Billing challenges: Potential denials if the link between medication and constipation is not well documented.

Specialty Focus

Medical Specialties

Gastroenterology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Pharmacology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Drug-induced constipation is a significant clinical concern, impacting patient quality of life and healthcare utilization. It can lead to increased visits to healthcare providers, potential hospitalizations for severe cases, and a need for additional treatments. Understanding the epidemiology of this condition is essential for healthcare providers to implement preventive measures and optimize patient care, especially in populations frequently prescribed constipating medications.

ICD-9 vs ICD-10

Drug-induced constipation is a significant clinical concern, impacting patient quality of life and healthcare utilization. It can lead to increased visits to healthcare providers, potential hospitalizations for severe cases, and a need for additional treatments. Understanding the epidemiology of this condition is essential for healthcare providers to implement preventive measures and optimize patient care, especially in populations frequently prescribed constipating medications.

Reimbursement & Billing Impact

Reimbursement considerations include verifying that the diagnosis is supported by clinical evidence and that the treatment plan addresses the drug-induced nature of the condition. Common denials may arise from insufficient documentation linking the medication to the gastrointestinal symptoms. Best practices include maintaining thorough records of medication changes and patient responses to treatment adjustments.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by K59.03?

K59.03 specifically covers constipation that is directly attributable to the use of medications. This includes cases where the patient has a history of normal bowel function prior to starting a new medication known to cause constipation.

When should K59.03 be used instead of related codes?

K59.03 should be used when constipation is clearly linked to drug use, as opposed to other forms of constipation which may not have a pharmacological cause. It is important to document the specific medication responsible for the condition.

What documentation supports K59.03?

Documentation should include a comprehensive medication list, details of the onset of constipation symptoms in relation to medication initiation, and any previous bowel habits to establish a clear connection.